Headquarters
2265 UPPER MIDDLE RD E SUITE 602, OAKVILLE, ON L6H 0G5, CA
OAKVILLE, ON, CA
Cardiol Therapeutics, Inc
From the company
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its lead small-molecule drug candidate, CardiolRx™, modulates inflammasome pathway activation and is being evaluated in clinical trials for pericarditis, myocarditis, and heart failure. The company is also developing CRD-38, a novel subcutaneously administered drug formulation intended for the treatment of inflammatory heart disease.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.